Drone Policy 2023 - Information Technology Development Agency 2026
This part of the Ayush scheme focuses on keeping a close watch on the safety of Ayurveda, Read More... Siddha, Unani, and Homoeopathy (ASU&H) drugs and checking for any fake or misleading ads about them. Read less
Details
The Ministry of Ayush, Government of India, runs a vital initiative under the 'Ayush Oushadhi Gunvatta evam Uttpadan Samvardhan Yojana' (AOGUSY). This component specifically targets the 'Pharmacovigilance of ASU&H Drugs Including Surveillance of Misleading Advertisements'. It's all about making sure the Ayush medicines you use are safe and that advertisements you see are honest.
What Is This Scheme?
Simply put, this initiative is designed to collect information, sort it, and study it to prove that ASU&H drugs are safe. It documents proof of their safety and keeps an eye on ads that might be making false claims about these medicines or the Ayush systems themselves.
Who Can Benefit From This Scheme?
The scheme directly benefits the public by ensuring the safety of Ayush medicines. It also supports Ayush practitioners and institutions by providing them with a system to report any issues and contributing to the overall credibility of the Ayush sector.
Why This Scheme Is Important
It's crucial for public health and trust. By monitoring drug reactions and cracking down on misleading ads, the scheme helps build confidence in Ayush medicines and protects consumers from potentially harmful products or deceptive marketing.
Objective
Benefits
The following measures have been initiated under the Drone Policy 2023 to boost the drone sector:
- Giving a major boost to service delivery and governance through the use of drones in the difficult terrains of the state.
- Encouraging innovation and development in drone technology.
- Strengthening the Drone System Design and Manufacturing (DSDM) and Drone-Based Services (DES) ecosystem.
- Maximizing the benefits of drone technology for the state by promoting collaboration between industry, administration, and academia.
- Providing benefits under the policy to drone service providers, drone manufacturers, drone investors, drone-related startups, the youth of Uttarakhand, universities, ITIs, and polytechnic colleges.
- Developing a Public-Private Partnership (PPP) framework for the use of drones.
- Rewarding startups, companies, and individuals excelling in drone manufacturing and drone-related services.
- Establishing Drone Centers of Excellence.
- Introducing various incentive schemes.
Sources and references
Eligibility Criteria
Organisations looking to become Peripheral Pharmacovigilance Centres (PPvCs) need to meet certain standards:
- They must be Ayush teaching hospitals recognised by the relevant regulatory bodies like NCISM/NCH Act, IMCC Act, or HCC Act.
- Ayush healthcare facilities that are NABH accredited or run by the Government, or research council healthcare institutions are also eligible.
- The institution should have the necessary technical skills and equipment for monitoring and reporting drug safety.
- Priority is given to institutions that have already shown good results in similar projects.
- If an institution has received government funds before, it must have submitted all its utilisation certificates and have no negative remarks.
For Intermediary and National Centres:
- Only those institutions which the Ministry of Ayush officially designates as National or Intermediary Pharmacovigilance Centres can apply.
How To Apply
Institutions interested in becoming Peripheral Pharmacovigilance Centres (PPvCs) should follow these steps:
- Fill out the application form and prepare a concept note detailing your plan to participate as a PPvC.
- Sign an undertaking promising to follow all pharmacovigilance rules and reporting requirements.
- Provide details about your current infrastructure, staff, and equipment.
- Submit a detailed project proposal that includes your goals, action plan, expected milestones, and a breakdown of costs.
- Get a recommendation letter from the head of your institution.
- If you've received government funding before, you’ll need to submit your utilization certificates.
- Be ready to submit any other documents that might be requested.
For Intermediary and National Centres, the process is by designation from the Ministry of Ayush.
Documents Required
- Completed application form and a concept note for PPvC participation.
- An undertaking to follow pharmacovigilance norms and reporting duties.
- Details of your institution's existing infrastructure, manpower, and equipment.
- A project proposal covering objectives, action plan, key milestones, and budget details.
- A recommendation letter from the head of the institution.
- Utilization certificates for any previous government-funded projects, if applicable.
- Any other supporting documents as may be required by the Ministry.
FAQ’s
What is the main goal of the "Pharmacovigilance of ASU&H Drugs Including Surveillance of Misleading Advertisements" initiative?
The primary aim is to create a national system for monitoring the safety of ASU&H drugs and to actively watch for and address any misleading advertisements related to these Ayush medicines.
Can you explain what pharmacovigilance means for ASU&H drugs?
Pharmacovigilance in the context of ASU&H drugs involves systematically tracking and evaluating any adverse effects or other safety concerns that may arise from the use of these traditional and homoeopathic medicines.
Who is responsible for running this pharmacovigilance programme?
The Ministry of Ayush oversees this programme, working through the National Pharmacovigilance Co-ordination Centre and a network of other associated centres across the country.
How is the pharmacovigilance system structured?
The system operates on three levels: a central National Pharmacovigilance Co-ordination Centre, several Intermediary Pharmacovigilance Centres, and numerous Peripheral Pharmacovigilance Centres at the local level.
Which kinds of institutions are eligible to become Peripheral Pharmacovigilance Centres?
Institutions like Ayush teaching hospitals recognized by law, government-run or NABH-accredited healthcare facilities, and other government or research council healthcare institutions with the right infrastructure and expertise can apply to be PPvCs.
What are the key activities supported by this part of the scheme?
This initiative supports reporting of adverse drug reactions, monitoring of misleading ads, public awareness campaigns, research activities, and thorough data analysis related to Ayush drugs.
How is the surveillance of misleading advertisements carried out?
Information about misleading advertisements is collected from various sources, including practitioners, the public, industry players, and healthcare facilities. These reports are then reviewed to take appropriate regulatory action.
What kind of financial support is offered under this scheme?
Financial assistance is provided to pharmacovigilance centres to cover costs for staff, running awareness programmes, creating educational materials, managing unexpected expenses, and overall programme administration.
How are applications for these centres reviewed?
Applications are first looked at by the Intermediary Centre. After that, the National Pharmacovigilance Co-ordination Centre evaluates them before they are finally approved by the Ministry of Ayush.
Will an institution be disqualified if it has received government funding before?
No, past government funding is not a disqualifier. Institutions that have received government funds previously are still eligible, as long as they have settled all utilisation certificates and have no adverse remarks against them.
What are the main duties expected from a Peripheral Pharmacovigilance Centre?
PPvCs are responsible for reporting any adverse drug reactions they encounter, keeping an eye out for misleading advertisements, and working closely with their respective Intermediary Centres.
When and how are the funds disbursed to the selected centres?
Funds are released in stages. The selected centres need to submit progress reports and audited statements of their expenditure to the NPvCC periodically to receive further funding.
Why is this initiative considered important for public health?
This scheme is vital for public health because it helps ensure that ASU&H drugs are safe and reliable for consumption. It also protects people from using unsafe medicines and falling for deceptive advertising claims.
Click it and Unblock the Notifications
Sign in with Google